National Institutes of Health: Precancerous Conditions trials

The registry lists 14 Precancerous Conditions studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 7 have results posted.

Phase 1 3Phase 2 7Phase 3 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy ProtocolsRecruitingNCT02682667
• Pioglitazone for Oral Premalignant LesionsTerminatedNCT00951379Phase 2Results posted
• Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of MelanomaCompletedNCT00841204Phase 2Results posted
• Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal CancerCompletedNCT00468910Phase 2Results posted
• Lovastatin in Treating Patients At High Risk of MelanomaCompletedNCT00462280Phase 2Results posted
• Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial DysplasiaCompletedNCT00368927Phase 2Results posted
• Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal NeoplasiaCompletedNCT00335504Phase 2Results posted
• Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon PolypsCompletedNCT00118365Phase 3Results posted
• Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the LungTerminatedNCT01013831Phase 1
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic MastocytosisCompletedNCT00132015Phase 2
• Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type IICompletedNCT00099112
• Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform NeurofibromasCompletedNCT00053937Phase 1
• Collection of Blood, Bone Marrow, Tumor or Tissue SamplesCompletedNCT00043615
• Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerCompletedNCT00003451Phase 1